CAS:931117-61-2|2-​[2-​[[4-​[(5S)​-​5-​[[[(5-Chloro-​2-​thienyl)​carbonyl]​amino]​methyl]​-​2-​oxo-​3-​oxazolidinyl]​phenyl]​amino]​ethoxy]​-acetic Acid Hydrochloride

CAS:931117-61-2|2-​[2-​[[4-​[(5S)​-​5-​[[[(5-Chloro-​2-​thienyl)​carbonyl]​amino]​methyl]​-​2-​oxo-​3-​oxazolidinyl]​phenyl]​amino]​ethoxy]​-acetic Acid Hydrochloride

Catalogue Number:C421840
Chemical Name:2-​[2-​[[4-​[(5S)​-​5-​[[[(5-Chloro-​2-​thienyl)​carbonyl]​amino]​methyl]​-​2-​oxo-​3-​oxazolidinyl]​phenyl]​amino]​ethoxy]​-acetic Acid Hydrochloride
Synonyms:Rivaroxaban Impurity A Hydrochloride
Impurity:Rivaroxaban Impurity A Hydrochloride
CAS Number:931117-61-2
Alternate CAS #
Free Base: 931204-39-6
Molecular Formula:C₁₉H₂₀ClN₃O₆S • H Cl
Appearance:White to Pale Red Solid
Melting Point:172-176ºC
Molecular Weight:453.90 + (36.46)
Storage:4°C, Hygroscopic
Solubility:DMSO (Slightly), Methanol (Slightly)
Stability
Hygroscopic
Category:Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
Applications:2-​[2-​[[4-​[(5S)​-​5-​[[[(5-​chloro-​2-​thienyl)​carbonyl]​amino]​methyl]​-​2-​oxo-​3-​oxazolidinyl]​phenyl]​amino]​ethoxy]​-acetic Acid Hydrochloride is a metabolite of Rivaroxaban (R538000) which is a novel antithrombotic agent. Rivaroxaban is also a highly potent and selective, direct FXa inhibitor.
References:Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005)
To ensure the stability of our products, the efficient express delivery service will be used. We also guarantee that the products will be shipped in the box with layers of tapes to protect them against damage. The extremely low temperature products will be wrapped with dried ice, and the low temperature products will be delivered with ice bags. As for the products stored at room temperature, they will not be packed with ice bags or dried ice. Taskcm is committed to providing cost-effective products that facilitate drug delivery with our customers.
Email:sales@ebclink.com

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *